Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Remission”

569 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 569 results

Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Not applicableLooking for participantsNCT05184582
What this trial is testing

Physical Exercise During Preoperative Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Karolinska Institutet 712
Not applicableUnknownNCT01612247
What this trial is testing

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
University of Vermont 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04806646
What this trial is testing

Tailored Sonidegib Schedule After Complete Response in BCC

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 21
Testing effectiveness (Phase 2)Study completedNCT04477486
What this trial is testing

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma (MCL)
AbbVie 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07397442
What this trial is testing

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III
Beijing Friendship Hospital 19
Post-approval studies (Phase 4)Looking for participantsNCT07101588
What this trial is testing

Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Chinese PLA General Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT01844986
What this trial is testing

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Who this might be right for
Newly DiagnosedAdvanced Ovarian CancerFIGO Stage III-IV+4 more
AstraZeneca 450
Not applicableStudy completedNCT01360125
What this trial is testing

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

Who this might be right for
Leukemia
SWOG Cancer Research Network 310
Very early researchEnded earlyNCT02966730
What this trial is testing

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Who this might be right for
Follicular LymphomaFollicular Lymphoma, Grade 1Follicular Lymphoma, Grade 2+1 more
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT01627132
What this trial is testing

Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial

Who this might be right for
Chronic Myeloid Leukemia
Shimousa Hematology Study Group 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06777264
What this trial is testing

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell ALL
First Affiliated Hospital of Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT05103293
What this trial is testing

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Who this might be right for
Pathological Conditions, Signs and Symptoms
Zhejiang Cancer Hospital 86
Testing effectiveness (Phase 2)Looking for participantsNCT06601309
What this trial is testing

Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06608732
What this trial is testing

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableNot Yet RecruitingNCT06755567
What this trial is testing

Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerNeoadjuvant TherapyImmunotherapy+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 750
Not applicableStudy completedNCT03820557
What this trial is testing

Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 44
Early research (Phase 1)Study completedNCT01690624
What this trial is testing

BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse

Who this might be right for
Leukemia, Myeloid, Acute
Boehringer Ingelheim 30
Not applicableNot Yet RecruitingNCT06131632
What this trial is testing

Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Inflammatory Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Not applicableApproved For MarketingNCT03079687
What this trial is testing

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Who this might be right for
Ovarian Cancer
AstraZeneca
Load More Results